Mortensen, Camilla Bekker http://orcid.org/0000-0001-5202-3552
Andersen-Ranberg, Nina Christine http://orcid.org/0000-0002-0804-1064
Poulsen, Lone Musaeus
Granholm, Anders http://orcid.org/0000-0001-5799-7655
Rasmussen, Bodil Steen http://orcid.org/0000-0003-2190-145X
Kjær, Maj-Brit Nørregaard http://orcid.org/0000-0002-6536-0504
Lange, Theis
Ebdrup, Bjørn H. http://orcid.org/0000-0002-2590-5055
Collet, Marie Oxenbøll
Andreasen, Anne Sofie http://orcid.org/0000-0002-8759-3405
Bestle, Morten Heiberg http://orcid.org/0000-0001-6585-2659
Uslu, Bülent
Pedersen, Helle Scharling
Nielsen, Louise Gramstrup
Hästbacka, Johanna http://orcid.org/0000-0002-3613-7231
Jensen, Troels Bek
Damgaard, Kjeld
Sommer, Trine
Morgen, Matthew
Dey, Nilanjan http://orcid.org/0000-0002-8283-2614
Citerio, Guiseppe
Estrup, Stine http://orcid.org/0000-0002-1467-7085
Egerod, Ingrid http://orcid.org/0000-0002-9576-4390
Samuelson, Karin
Perner, Anders
Mathiesen, Ole http://orcid.org/0000-0003-4544-0619
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-term outcomes with haloperidol versus placebo in acutely admitted adult ICU patients with delirium
https://doi.org/10.1007/s00134-023-07282-7
Pharmacological interventions for prevention and management of delirium in intensive care patients: a systematic overview of reviews and meta-analyses
https://doi.org/10.1136/bmjopen-2018-024562
Funding for this research was provided by:
Innovationsfonden (4108-00011B)
Region Sjælland
Lund University
Article History
Received: 22 September 2023
Accepted: 16 November 2023
First Online: 3 January 2024
Declarations
:
: AG, MBNK, MOC and AP are affiliated with the Department of Intensive Care at Rigshospitalet, which has received funding for other projects from The Novo Nordisk Foundation, Pfizer, and Fresenius Kabi, Sygeforsikringen “danmark”. AP has received an honorarium from Novartis for the participation in an advisory board. AP is on DSMB for The Mega-Rox trial, UK-Rox trial, Bone Zone trial. BSR are affiliated with the Department of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark, which has received funding for other project from Novo Nordisk Foundation, Danish Ministry of Education and Science and Beckett Foundation. MHB are affiliated with the Department of Anaesthesia and Intensive Care at Copenhagen University Hospital – North Zealand, which has received funding for other research projects from The Novo Nordisk Foundation, Sygeforsikringen “danmark”, Toyota Foundation, A.P. Moeller Foundation, Frimodt-Heineke Foundation, Svend Andersen Foundation, Ehrenreich Foundation, and Olga Bryde Nielsen Foundation, and has conducted contract research for AM-Pharma (the REVIVAL trial) and Inotrem (ASTONISH trial). MHB has received an honorarium from AM-Pharma for participation in an advisory board. TL is a member of DSMB for Novo Nordisk and Leo Pharma study. BE is part of the Advisory Board of Eli Lilly Denmark A/S, Janssen-Cilag, Lundbeck Pharma A/S, and Takeda Pharmaceutical Company Ltd; and has received lecture fees from Bristol-Myers Squibb, Boehringer Ingelheim, Otsuka Pharma Scandinavia AB, Eli Lilly Company, and Lundbeck Pharma A/S. JH has received funding from Paulo foundation, Finska Läkaresällskapet, NordForsk and Tor och Kirsti Johanssons Hjärt och Cancerstiftelse. GC has received istituational research grants from Neuroptics and Integra and is a board member at Neuroptics, Integra, Biogen, Invex Therapeutics and Idorsia. All other authors have no conflicts to disclose.